|
|
Volumn 528, Issue 1-3, 2002, Pages 70-76
|
|
Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli
a
a
|
|
Author keywords
Adoptive immunotherapy; Inclusion body; Interleukin 21; LAK; Refolding
|
|
Indexed keywords
CD3 ANTIGEN;
INTERLEUKIN 21;
MONOCLONAL ANTIBODY CD3;
RECOMBINANT CYTOKINE;
UNCLASSIFIED DRUG;
ADOPTIVE IMMUNOTHERAPY;
ALPHA HELIX;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BILE DUCT CARCINOMA;
CANCER INHIBITION;
CELL INCLUSION;
CELL LINE;
CELL PROLIFERATION;
CIRCULAR DICHROISM;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG EFFECT;
DRUG MECHANISM;
ESCHERICHIA COLI;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
MONONUCLEAR CELL;
NONHUMAN;
OXIDATION REDUCTION REACTION;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN BINDING;
PROTEIN EXPRESSION;
PROTEIN FOLDING;
PROTEIN SECONDARY STRUCTURE;
T LYMPHOCYTE;
ANTINEOPLASTIC AGENTS;
BASE SEQUENCE;
CYTOTOXICITY, IMMUNOLOGIC;
DNA, RECOMBINANT;
ESCHERICHIA COLI;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
INCLUSION BODIES;
INTERLEUKINS;
KILLER CELLS, LYMPHOKINE-ACTIVATED;
MOLECULAR SEQUENCE DATA;
NEOPLASMS;
PROTEIN ENGINEERING;
PROTEIN FOLDING;
RECOMBINANT PROTEINS;
T-LYMPHOCYTE SUBSETS;
TUMOR CELLS, CULTURED;
ESCHERICHIA COLI;
|
|
EID: 0037174127
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(02)03254-4 Document Type: Article |
|
Times cited : (71)
|
|
References (27)
|
